The CoV2ID: Detection and Therapeutics Oligo Database for SARS-CoV-2 evaluates WHO testing methods considering the SARS-CoV-2 genetic diversity.

Users can:

– identify the most conserved RT-qPCR primers and probes in near 1000 SARS-CoV-2 genomes;

– identify potential mutations that could affect the binding efficiency of oligonucleotides:

– detect putative false positives resulting from binding of oligonucleotides in other human coronavirus;

– identify the most conserved SARS-CoV-2 genomic regions for design of new detection methods.

– find a quick guide to perform laboratory testing for SARS-CoV-2 with detailed protocols.